Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients

Toxicological Sciences

Volumn 142, Issue 2, 2014, Pages 436-444

  Woolbright, Benjamin L ^a   McGill, Mitchell R ^a   Staggs, Vincent S ^a   Winefield, Robert D ^a   Gholami, Parviz ^a   Olyaee, Mojtaba ^a   Sharpe, Matthew R ^a   Curry, Steven C ^b,c   Leejj, William M ^d   Jaeschke, Hartmut ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Acetaminophen; Acute liver failure; Bile acid; Cholestasis; Hepatotoxicity; Serum biomarker

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; GLYCODEOXYCHOLIC ACID; PARACETAMOL;

ACUTE LIVER FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG INDUCED DISEASE; FEMALE; HUMAN; LIVER INJURY; LIVER TOXICITY; MALE; MASS SPECTROMETRY; OUTCOME ASSESSMENT; PROGNOSIS; PROTHROMBIN TIME; SURVIVAL; BLOOD; CASE CONTROL STUDY; CHOLESTASIS; DRUG OVERDOSE; DRUG-INDUCED LIVER INJURY; LIVER FUNCTION TEST; MIDDLE AGED; PREDICTIVE VALUE; YOUNG ADULT;

ACETAMINOPHEN; ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CHOLESTASIS; DRUG OVERDOSE; DRUG-INDUCED LIVER INJURY; FEMALE; GLYCODEOXYCHOLIC ACID; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; YOUNG ADULT;

EID: 84921985239     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfu195     Document Type: Article

References (39)

1. Alnouti, Y., Csanaky, I. L., and Klaassen, C. D. (2008). Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 873, 209-217.
2. Antoine, D. J., Jenkins, R. E., Dear, J. W., Williams, D. P., McGill, M. R., Sharpe, M. R., Craig, D. G., Simpson, K. J., Jaeschke, H., and Park, B. K. (2012). Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J. Hepatol. 56, 1070-1079.
3. Antoine, D. J., Dear, J. W., Lewis, P. S., Platt, V., Coyle, J., Masson, M., Thanacoody, R. H., Gray, A. J., Webb, D. J., Moggs, J. G., et al. (2013). Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 58, 777-787.
4. Bechmann, L. P., Kocabayoglu, P., Sowa, J. P., Sydor, S., Best, J., Schlattjan, M., Beilfuss, A., Schmitt, J., Hannivoort, R. A., Kilicarslan, A., et al. (2013). Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis. Hepatology 57, 1394-1406.
5. Bhushan, B., Borude, P., Edwards, G., Walesky, C., Cleveland, J., Li, F., Ma, X., and Apte, U. (2013). Role of bile acids in liver injury and regeneration following acetaminophen overdose. Am. J. Pathol. 183, 1518-1526.
6. Chiang, J. Y. (2013). Bile acid metabolism and signaling. Compr. Physiol. 3, 1191-1212.
7. Galle, P. R., Theilmann, L., Raedsch, R., Otto, G., and Stiehl, A. (1990). Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 12, 486-491.
8. González, R., Cruz, A., Ferrín, G., López-Cillero, P., Fernández-Rodríguez, R., Bricenõ, J., Gómez, M. A., Rufián, S., Mata, Mde L., Martínez-Ruiz, A., et al. (2011). Nitric oxide mimics transcriptional and post-translational regulation during a-tocopherol cytoprotection against glycochenodeoxycholate-induced cell death in hepatocytes. J. Hepatol. 55, 133-144.
9. Guicciardi, M. E., Malhi, H., Mott, J. L., and Gores, G. J. (2013). Apoptosis and necrosis in the liver. Compr. Physiol. 3, 977-1010. Hoekstra, L. T., van Lienden, K. P., Schaap, F. G., Chamuleau, R. A., Bennink, R. J., and van Gulik, T. M. (2012). Can plasma bile salt, triglycerides, and apoA-V levels predict liver regeneration? World J. Surg. 36, 2901-2908.
10. Jaeschke, H., McGill, M. R., and Ramachandran, A. (2012). Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab. Rev. 44, 88-106.
11. Jang, J. H., Rickenbacher, A., Humar, B., Weber, A., Raptis, D. A., Lehmann, K., Stieger, B., Moritz, W., Soll, C., Georgiev, P., et al. (2012). Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation. Hepatology 56, 209-218.
12. Jemnitz, K., Veres, Z., and Vereczkey, L. (2010). Contribution of high basolateral bile salt efflux to the lack of hepatotoxicity in rat in response to drugs inducing cholestasis in human. Toxicol. Sci. 115, 80-88.
13. Lee, W. M. (2012). Liver: determining prognosis in acute liver failure. Nat. Rev. Gastroenterol. Hepatol. 9, 192-194.
14. Luo, L., Schomaker, S., Houle, C., Aubrecht, J., and Colangelo, J. L. (2014). Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents. Toxicol. Sci. 137, 12-25.
15. Malhi, H., Guicciardi, M. E., and Gores, G. J. (2011). Hepatocyte death: a clear and present danger . Physiol. Rev.90, 1165-1194.
16. McGill, M. R., and Jaeschke, H. (2014). Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients. Expert Opin. Drug Metab. Toxicol. 10, 1005-1017.
17. McGill, M. R., Cao, M., Svetlov, A., Sharpe, M. R., Williams, C. D., Curry, S. C., Farhood, A., Jaeschke, H., and Svetlov, S. I. (2014a). Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans. Biomarkers 19, 222-230.
18. McGill, M. R., Sharpe, M. R., Williams, C. D., Taha, M., Curry, S. C., and Jaeschke, H. (2012). The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J. Clin. Invest. 122, 1574-1583.
19. McGill, M. R., Staggs, V. S., Sharpe, M. R., Lee, W. M., Jaeschke, H., and the Acute Liver Failure Study Group. (2014b). Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology. Advance Access published Jun 13. doi: 10.1002/hep.27265.
20. Ni, H. M., Boggess, N., McGill, M. R., Lebofsky, M., Borude, P., Apte, U., Jaeschke, H., and Ding, W. X. (2012). Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. Toxicol. Sci. 127, 438-450.
21. Padda, M. S., Sanchez, M., Akhtar, A. J., and Boyer, J. L. (2011). Drug-induced cholestasis. Hepatology 53, 1377-1387.
22. Péan, N., Doignon, I., Garcin, I., Besnard, A., Julien, B., Liu, B., Branchereau, S., Spraul, A., Guettier, C., Humbert, L., et al. (2013). The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice. Hepatology 58, 1451-1460.
23. Ramachandran, A., McGill, M. R., Xie, Y., Ni, H. M., Ding, W. X., and Jaeschke, H. (2013). Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 58, 2099-2108.
24. Rutherford, A., King, L. Y., Hynan, L. S., Vedvyas, C., Lin, W., Lee, W. M., Chung, R. T., the Acute Liver Failure Study Group. (2012). Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology 143, 1237-1243.
25. Schmidt, L. E., and Larsen, F. S. (2007). MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 45, 789-796.
26. Schomaker, S., Warner, R., Bock, J., Johnson, K., Potter, D., Van Winkle, J., and Aubrecht, J. (2013). Assessment of emerging biomarkers of liver injury in human subjects. Toxicol. Sci. 132, 276-283.
27. Shlomai, A., Halfon, P., Goldiner, I., Zelber-Sagi, S., Halpern, Z., Oren, R., and Bruck, R. (2013). Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C. J. Viral Hepat. 20, 95-102.
28. Spivey, J. R., Bronk, S. F., and Gores, G. J. (1993). Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J. Clin. Invest. 92, 17-24.
29. Trottier, J., Białek, A., Caron, P., Straka, R. J., Heathcote, J., Milkiewicz, P., and Barbier, O. (2012). Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study. Dig. Liver Dis. 44, 303-310.
30. Trottier, J., Białek, A., Caron, P., Straka, R. J., Milkiewicz, P., and Barbier, O. (2011). Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting. PLoS One 6, e22094.
31. Weerasinghe, S. V., Jang, Y. J., Fontana, R. J., and Omary, M. B. (2014). Carbamoyl phosphate synthetase-1 is a rapid turnover biomarker in mouse and human acute liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 307, G355-G364.
32. Woolbright, B. L., Antoine, D. J., Jenkins, R. E., Bajt, M. L., Park, B. K., and Jaeschke, H. (2013). Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice. Toxicol. Appl. Pharmacol. 273, 524-531.
33. Woolbright, B. L., and Jaeschke, H. (2012). Novel insight into mechanisms of cholestatic liver injury. World J. Gastroenterol. 18, 4985-4993.
34. Woolbright, B. L., Li, F., Gholami, P., Dorko, K., Kumer, S., Schmitt, T., Forster, T., Olyaee, M., Hagenbuch, B., and Jaeschke, H. (2014a). Human pathophysiological concentrations of bile salts induce necrosis in primary human hepatocytes. FASEB J. 28(Suppl.), 398.1 (Abstract).
35. Woolbright, B. L., Li, F., Xie, Y., Farhood, A., Fickert, P., Trauner, M., and Jaeschke, H. (2014b). Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice. Toxicol. Lett. 228, 56-66.
36. Xie, Y., McGill, M. R., Dorko, K., Kumer, S. C., Schmitt, T. M., Forster, J., and Jaeschke, H. (2014). Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. Toxicol. Appl. Pharmacol. 279, 266-274.
37. Yamazaki, M., Miyake, M., Sato, H., Masutomi, N., Tsutsui, N., Adam, K. P., Alexander, D. C., Lawton, K. A., Milburn, M. V., Ryals, J. A., et al. (2013). Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats. Toxicol. Appl. Pharmacol. 268, 79-89.
38. Zhang, Y. F., He, W., Zhang, C., Liu, X. J., Lu, Y., Wang, H., Zhang, Z. H., Chen, X., and Xu, D. X. (2014). Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necroptosis during acetaminophen-evoked acute liver failure in mice. Toxicol. Lett. 225, 445-453.
39. Zhang, Y., Hong, J. Y., Rockwell, C. E., Copple, B. L., Jaeschke, H., and Klaassen, C. D. (2012). Effect of bile duct ligation on bile acid composition in mouse serum and liver. Liver Int. 32, 58-69.